Rakuten Medical
-
CDSCO gives nod to Rakuten Medical to start phase 3 trial for cancer drug
The multi-centre, randomised, open-label, global Phase 3 study of Alluminox treatment using ASP-1929 will evaluate the efficacy and safety of…
Read More » -
Rakuten Medical launches India subsidiary
Mumbai-based company plans to develop and commercialise treatments based on the Alluminox platform in India Rakuten Medical (Rakuten Medical) has…
Read More » -
Rakuten Medical in strategic partnership with Karkinos Healthcare
Rakuten Medical and Karkinos Healthcare announced a strategic collaboration to expand the reach of novel cancer care to India. This…
Read More »